+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

Anthrax - Pipeline Insight, 2024 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chikungunya - Pipeline Insight, 2024 - Product Thumbnail Image

Chikungunya - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Marburg virus disease - Pipeline Insight, 2024 - Product Thumbnail Image

Marburg virus disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Antibiotic Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Antibiotic Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 100 Pages
  • Global
From
From
From
From
From
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
From
From
From
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
Loading Indicator